The guanidine alkaloids, dihydropulchranin A (2), prepared from pulchranin A from the sponge Monanchora pulchra, and hexadecylguanidine (3), a synthetic analog of pulchranins, were studied for their TRPV channel-regulating activities. Compound 2 was active as an inhibitor of rTRPV1 and hTRPV3 receptors with EC 50 values of 24.3 and 59.1 M, respectively. Hexadecylguanidine (3) was not active against these receptors.
Guanidine alkaloids represent a well-known group of secondary metabolites from tropical and Far-Eastern marine sponges [1] [2] [3] [4] . For instance, Monanchora pulcha was proved to be a rich source of bioactive alkaloids of this structural class [5] [6] [7] [8] [9] [10] [11] [12] , including cytotoxic pentacyclic alkaloids [5] [6] [7] 9] , bicyclic bisguanidine metabolities, inductors of iNOS in macrophages [11] , acyclic guanidine compounds and inhibitors of some TRPV receptors [8, 10] . Our previous studies on the structure-activity relationship of the acyclic guanidine alkaloids have shown that the length of the hydrocarbon chain of the hydroxylated unsaturated fatty acid moiety is important to the inhibitory action of pulchranins A-C against TRPV receptors [8, 10] . The most active of them, pulchranin A (1), contains a C 13 open chain, with pulchranins B and C having C 12 and C 11 hydrocarbon chains, respectively [10] .
In continuation of our study on the structure-activity relationship of the acyclic guanidine alkaloids, herein we report two new pulchranin derivatives (2, 3), as well as their inhibitory activities to rTRPV1, hTRPV3, and rTRPA1 receptors. TRPV1 and TRPV3 belong to the "vanilloid" subfamily of TRP-receptors and have about 40% identity of amino acid sequence. Both TRPV1 and TRPV3 are activated by 2APB. These ionic channels are involved in the transmission/modulation of pain and regulation of body temperature. TRPA1 is a single member of the "ankirin" subfamily of TRP-receptors and, among all the TRP subfamilies, is phylogenetically the closest to TRPVs. Like TRPV1, TRPA1 is activated by lidocaine, AITC, pungent extracts from garlic and onion and their active components, allicin and alliin. Carvacrol and thymol activate both TRPA1 and TRPV3. TRPV1, TRPV3 and TRPA1 belong to the group of thermosensitive ion channels with distinct thermal activation thresholds (>43°C for TRPV1, > 34−38°C for TRPV3, and <17°C for TRPA1). Inhibitors of TRPreceptors, particularly low molecular weight compounds, are of interest as potential therapeutic agents [13] . The action of dihydropulchranin A (2), as well as pulchranin A (1), led to a concentration-dependent decrease of [Ca 2+ ] in CHO cells, expressed rTRPV1, hTRPV3 and rTRPA1 after preincubation at 37°C for 30 minutes (Figure 3 .). Hexadecylguanidine (3) produced practically no effect on [Ca 2+ ] responses in TRP-expressing cells induced by receptor specific agonists in concentrations up to 0.2 mg/mL. Responses were measured as the pseudoratio (ΔFI/FI) determined using the following formula ΔFI/FI=(FI-FI base )/FI base , where FI is the measured peak fluorescence intensity, F base is the fluorescence intensity in nonstimulated cells. Inhibitory activity was expressed as percentage of the response in control experiment (untreated by dihydropulchranin A (2) cells). Data are expressed as mean+s.e.mean (n= 4-8).
Dihydropulchranin A (2), with a hydroxyl group at position 7, but which has no double bonds, displays activity against rTRPV1 and hTRPV3 receptors comparable with that of pulchranin A (1), which contains the hydroxyl group and a Δ 4 double bond (Table  2) . Therefore, the presence of the double bond is not crucial for manifestation of these properties. On the contrary, hexadecylguanidine (3) lacks a hydroxyl group, but possesses a longer chain (C 16 ) in comparison with natural pulchranins.
As 3 shows no inhibition (Table 2) , it is clearly indicated that an optimal hydrophobicity of the alkyl fragments, as well as the presence of the hydroxyl group at position 7 play an important role in inhibitory activities against rTRPV1 and hTRPV3 receptors in this series of compounds. This opens some perspective for the further search for new inhibitors, acting on these molecular targets.
In conclusion, compound 2 was proved to be active as an inhibitor of the rTRPV1 and hTRPV3 receptors with EC 50 values of 24.3 and 59.1 M, respectively. Further search of new inhibitors of the TRP-receptors among metabolites of the Far-Eastern sponges, their synthetic and semi-synthetic derivatives and analogs are in progress.
Experimental
General: Hexadecylamine and 1H-pyrazole-1-carboxamidine hydrochloride were obtained from Aldrich. Optical rotations were measured using a Perkin-Elmer 343 polarimeter. The 1 H and 13 C NMR spectra were recorded on an Avance III-700 spectrometer at 700 and 175 MHz, respectively, Chemical shifts were referenced to the corresponding residual solvent signal (δ H 3.30/δ C 49.60 for CD 3 OD). ESI mass spectra (including HR ESI-MS) were obtained on an Agilent 6510 Q-TOF LC-MS spectrometer by direct infusion in MeOH. Low-pressure column liquid chromatography was performed using YMC GEL ODS-A. Si gel plates (4.5×6.0 cm, 5-17 µm, Sorbfil) were used for TLC. HPLC was performed using an Agilent Series 1100 Instrument equipped with a differential refractometer RID-10A and YMC-ODS-Am (250×10 mm, 5 μm) column.
Dihydropulchranin A TFA salt (2): PtO 2 was added to a solution of 1 (2.6 mg) in MeOH (0.5 mL) and stirred under H 2 at 25°C for 1 h. Removal of the catalyst by filtration and evaporation of the solvent gave 2 (2.5 mg) as a colorless solid.
[α] D -9.4 (c 0.25, EtOH). 1 H NMR: Guanidine derivatives as inhibitor of the rTRPV1 and hTRPV3 receptors Natural Product Communications Vol. 10 (7) 2015 1173
Activities on TRP-receptors:
The CHO cell lines stably expressing rat TRPV1, human TRPV3 and rat TRPA1 were generated using the T-Rex System (Invitrogene) according to the manufacturer's instructions. Fluorescent assays were performed using NOVOstar (BMG LABTECH, Germany), as described in [8] . The buffer alone (control) or serial dilutions of pulchranins A, dihydropulchranin A (2) and hexadecylguanidine (3) were added to the cells loaded with the cytoplasmic calcium indicator Fluo-4AM. After a 30 min incubation at 37°C, changes in cell fluorescence ( ex =485 nM,  em =520 nM) were monitored before and after the addition of the relevant agonist (500 nM capsaicin, 200 M 2APB, 100 M AITC for rTRPV1, hTRPV3 and rTRPA1 correspondently). The measurements were performed at pH 7.4 at 25°C. Curve fitting and parameter estimations were performed with Microsoft Excel 2003 and Origin 7.0 (OriginLab Corporation, USA.). The EC 50 values were determined as the concentration of test substance required to produce half-maximal decreases in [Ca 2+ ].
